Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.

Matakidou A, Eisen T, Houlston RS.

Mutagenesis. 2003 Jul;18(4):377-85. Review.

PMID:
12840112
[PubMed - indexed for MEDLINE]
Free Article
2.

CYP1A1 polymorphisms and lung cancer risk: a meta-analysis.

Houlston RS.

Pharmacogenetics. 2000 Mar;10(2):105-14.

PMID:
10761998
[PubMed - indexed for MEDLINE]
3.

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, Wang Y, Lin D.

Hum Mutat. 2006 Jan;27(1):110-7.

PMID:
16287156
[PubMed - indexed for MEDLINE]
4.

Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population.

Kiyohara C, Horiuchi T, Miyake Y, Takayama K, Nakanishi Y.

Oncol Rep. 2010 May;23(5):1361-8.

PMID:
20372852
[PubMed - indexed for MEDLINE]
5.

P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.

Dai S, Mao C, Jiang L, Wang G, Cheng H.

Hum Genet. 2009 Jun;125(5-6):633-8. doi: 10.1007/s00439-009-0664-3. Epub 2009 Apr 9.

PMID:
19357867
[PubMed - indexed for MEDLINE]
6.

Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Ye XH, Bu ZB, Feng J, Peng L, Liao XB, Zhu XL, Sun XL, Yu HG, Yan DF, Yan SX.

Mol Biol Rep. 2014 Jan;41(1):373-85. doi: 10.1007/s11033-013-2871-1. Epub 2013 Nov 23.

PMID:
24271138
[PubMed - indexed for MEDLINE]
7.

Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.

Pierce LM, Sivaraman L, Chang W, Lum A, Donlon T, Seifried A, Wilkens LR, Lau AF, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1199-204.

PMID:
11097227
[PubMed - indexed for MEDLINE]
Free Article
8.

A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects.

Li Y, Qiu LX, Shen XK, Lv XJ, Qian XP, Song Y.

Lung Cancer. 2009 Oct;66(1):15-21. doi: 10.1016/j.lungcan.2008.12.009. Epub 2009 Jan 28.

PMID:
19178978
[PubMed - indexed for MEDLINE]
9.

Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors.

Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L, Shields PG, Burdette L, Chanock S, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):214-22.

PMID:
17301252
[PubMed - indexed for MEDLINE]
Free Article
10.

TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.

Zhuo XL, Cai L, Xiang ZL, Zhuo WL, Wang Y, Zhang XY.

Arch Med Res. 2009 May;40(4):299-305. doi: 10.1016/j.arcmed.2009.03.006. Epub 2009 Jun 4.

PMID:
19608020
[PubMed - indexed for MEDLINE]
11.

Genetic variants in cell cycle control pathway confer susceptibility to lung cancer.

Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, Wu X.

Clin Cancer Res. 2007 Oct 1;13(19):5974-81.

PMID:
17908995
[PubMed - indexed for MEDLINE]
Free Article
12.

Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.

Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, Dienemann H, Risch A, Bartsch H, Schmezer P.

Lung Cancer. 2007 Jan;55(1):25-34. Epub 2006 Oct 23.

PMID:
17059853
[PubMed - indexed for MEDLINE]
13.

XRCC1 polymorphism and lung cancer risk.

Schneider J, Classen V, Helmig S.

Expert Rev Mol Diagn. 2008 Nov;8(6):761-80. doi: 10.1586/14737159.8.6.761. Review.

PMID:
18999926
[PubMed - indexed for MEDLINE]
14.

A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.

De Feo E, Persiani R, La Greca A, Amore R, Arzani D, Rausei S, D'Ugo D, Magistrelli P, van Duijn CM, Ricciardi G, Boccia S.

Mutat Res. 2009 Apr 30;675(1-2):60-5. doi: 10.1016/j.mrgentox.2009.02.009. Epub 2009 Mar 3.

PMID:
19386249
[PubMed - indexed for MEDLINE]
15.

Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.

Zhuo XL, Li Q, Zhou Y, Cai L, Xiang ZL, Yuan W, Zhang XY.

Arch Med Res. 2009 Oct;40(7):625-34. doi: 10.1016/j.arcmed.2009.09.004.

PMID:
20082880
[PubMed - indexed for MEDLINE]
16.

Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis.

Zhang J, Zhuo WL, Zheng Y, Zhang YS.

Med Oncol. 2010 Jun;27(2):540-6. doi: 10.1007/s12032-009-9245-5. Epub 2009 Jun 5.

PMID:
19499352
[PubMed - indexed for MEDLINE]
17.

Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.

Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.

Lung Cancer. 2006 Apr;52(1):9-14. Epub 2006 Feb 24.

PMID:
16499995
[PubMed - indexed for MEDLINE]
18.

Combined effects of the p53 and p73 polymorphisms on lung cancer risk.

Schabath MB, Wu X, Wei Q, Li G, Gu J, Spitz MR.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):158-61.

PMID:
16434604
[PubMed - indexed for MEDLINE]
Free Article
19.

Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women.

Klinchid J, Chewaskulyoung B, Saeteng S, Lertprasertsuke N, Kasinrerk W, Cressey R.

Cancer Genet Cytogenet. 2009 Dec;195(2):143-9. doi: 10.1016/j.cancergencyto.2009.08.011.

PMID:
19963114
[PubMed - indexed for MEDLINE]
20.

TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.

Yan L, Zhang D, Chen C, Mao Y, Xie Y, Li Y, Huang Y, Han B.

Int J Cancer. 2009 Dec 15;125(12):2903-11. doi: 10.1002/ijc.24603.

PMID:
19623649
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk